-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on CME Group, Raises Price Target to $305

Benzinga·04/25/2025 15:16:31
Listen to the news
UBS analyst Alex Kramm maintains CME Group (NASDAQ:CME) with a Buy and raises the price target from $290 to $305.